icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Concomitant Medication Use (drug interactions) in Patients with Hepatitis C Genotype 1 Treated with Boceprevir Combination Therapy
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
F. Poordad1, E. Lawitz2, S. Gordon3, M. Bourlière4, J. Vierling5, T. Poynard6, A. Craxi7, M. Manns8, A. Alberti9, L. D. Pedicone10, M. Burroughs10, R. Lambert10, C. Brass10, J. Albrecht10 and S. Bruno11 1Cedars-Sinai Medical Center, Los Angeles, CA; 2Alamo Medical Research, San Antonio, TX; 3Henry Ford Hospital, Detroit, MI; 4Fondation Hopital Saint Joseph, Marseille, France; 5Baylor College of Medicine, Houston; 6APHP-UPMC Liver Center, Paris, France; 7University of Palermo, Palermo, Italy; 8Medical School of Hannover, Hannover, Germany; 9University of Padova, Padova, Italy; 10Merck, Sharp, & Dohme Corp., Whitehouse Station, NJ; 11A.O. Fatebenefratelli e Oftalmico, Milan, Italy

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif